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OBJECTIVES: Experimental studies on sepsis have demonstrated that ethyl pyruvate is endowed with antioxidant
and anti-inflammatory properties. This study aimed to investigate the effects of ethyl pyruvate on leukocyte-
endothelial interactions in the mesenteric microcirculation in a live Escherichia coli-induced sepsis model in rats.
METHODS: Male Wistar rats were administered an intravenous suspension of E. coli bacteria or were subjected
to a sham procedure. Three hours after bacterial infusion, the rats were randomized into the following groups:
a control group without treatment, a group treated with lactated Ringer’s solution (4 mL/kg, i.v.), and a group
treated with lactated Ringer’s solution (4 mL/kg, i.v.) plus ethyl pyruvate (50 mg/kg). At 24 h after bacterial
infusion, leukocyte-endothelial interactions were investigated using intravital microscopy, and the expression
of P-selectin and intercellular adhesion molecule-1 was evaluated via immunohistochemistry. White blood cell
and platelet counts were also determined at baseline and 3 h and 24 h after E. coli inoculation.
RESULTS: The non-treated and lactated Ringer’s solution-treated groups exhibited increases in the numbers of
rolling leukocytes (B2.5-fold increase), adherent cells (B3.0-fold), and migrated cells (B3.5-fold) compared
with the sham group. In contrast, treatment with Ringer’s ethyl pyruvate solution reduced the numbers of
rolling, adherent and migrated leukocytes to the levels observed in the sham group. Additionally, the
expression of P-selectin and intercellular adhesion molecule-1 was significantly increased on mesenteric
microvessels in the non-treated group compared with the sham group (po0.001). The expression of both
adhesion molecules was reduced in the other groups, with ethyl pyruvate being more effective than lactated
Ringer’s solution. Infusion of bacteria caused significant leukopenia (3 h), followed by leukocytosis with
granulocytosis (24 h). There was also an intense and progressive reduction in the number of platelets. However,
no differences were observed after treatment with the different solutions.
CONCLUSIONS: The presented data suggest that ethyl pyruvate efficiently reduces the inflammatory response in
the mesenteric microcirculation in an experimental model of sepsis induced by live E. coli and is associated, at
least in part, with down-regulation of P-selectin and intercellular adhesion molecule-1.
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’ INTRODUCTION
Systemic inflammatory response syndrome (SIRS) and
sepsis often affect the outcome of patients exposed to
trauma, hemorrhage and major surgery, particularly
among the elderly and immunocompromised (1,2).
Even with therapeutic interventions aimed at better
hemodynamic support and the development of new
generations of antibiotics, sepsis and its complications
are still responsible for high mortality rates in intensive
care units (1,3–5).
Microcirculatory changes may herald the onset of multiple
organ failure in critical conditions. These abnormalities
include a characteristic heterogeneity of blood flow and
decreased functional capillary density in patients with
established severe sepsis (6–9), which are associated with
tissue hypoxia (10) and organ dysfunction (11).
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BASIC RESEARCH
It has been shown that ethyl pyruvate improves survival
and ameliorates organ dysfunction in animal models of
ischemia-reperfusion injury, including hemorrhagic shock
(12) and endotoxic shock (13,14) models. The anti-inflam-
matory and anti-oxidant properties of ethyl pyruvate
observed in animal models of sepsis and septic shock
(15,16) and in in vitro experiments (17) have demonstrated
that ethyl pyruvate might be a promising therapeutic agent
(18). It has specifically been shown that ethyl pyruvate
ameliorates post-reperfusion deficits in the microvascular
blood flow in the gut and liver as well as ileal mucosal
hyperpermeability in mice subjected to mesenteric ischemia-
reperfusion (19). Therefore, the present study aimed to
investigate the effects of ethyl pyruvate, both in vivo and
in situ, on the mesenteric microcirculation and the endothe-
lial expression of P-selectin and intercellular adhesion
molecule (ICAM)-1 in a sepsis model induced by live
Escherichia coli in rats. This theme has been recently reviewed
in a comprehensive manner (20,21).
’ MATERIALS AND METHODS
Animals
Male Wistar rats weighing 200-250 g at the beginning of the
experiments were used. The animals were maintained at 23±2 ˚C
under a 12-h light/dark cycle and were allowed access to a
standard rat chow pellet diet and water ad libitum. The experi-
mental protocol was approved by the Ethical Committee of the
Heart Institute (InCor) of the University of São Paulo Medical
School and was performed according to the National Institutes of
Health guidelines for the use of experimental animals.
Experimental protocol
Animals were anesthetized with intraperitoneal sodium
pentobarbital (50 mg/kg). A right cervical incision was
performed, and the carotid artery and jugular vein were
dissected and cannulated with polyethylene catheters
(PE-50 coupled with PE-10). The catheters were filled with
heparinized saline and exteriorized to the dorsum. All
animals were then returned to their cages for recovery. The
venous catheter was subsequently used for the injection of
solutions, and the arterial catheter was used for monitor-
ing the mean arterial blood pressure (MAP) and for
collecting blood samples. On the day of the experiments,
the rats were administered an intravenous suspension of
E. coli bacteria (3-5x109 CFU/mL) or were subjected to a
sham procedure. Three hours after bacterial infusion, the
rats were randomized into the following groups: a control,
non-treated (NT) group, a group treated with lactated
Ringer ’s solution (LR group, 4 mL/kg), and a group
treated with lactated Ringer ’s solution (4 mL/kg) plus
ethyl pyruvate (REP group, 50 mg/kg). Commercially
available LR solution (Baxter International Inc, São Paulo,
SP, Brazil) was used as the control solution because of the
increased solubility and stability of ethyl pyruvate when
formulated in a calcium-containing balanced salt solution
such as LR (22) and in order to preclude any effects of the
electrolyte composition of the solutions on the observed
differences. The ethyl pyruvate was purchased from Sigma
Chemical Co (St Louis, MO, USA). The dose selected for this
study was based on previously published studies (15,19).
The direct MAP (mmHg) was recorded in unanesthetized rats
by connecting the arterial catheter to a pressure transducer
(Statham-Gould, P23 Db, Valley View, OH, USA) coupled to a
multichannel recorder (PowerLab Multirecord, USA). Rectal
temperature changes were simultaneously recorded. Arterial
blood gases and electrolytes, blood lactate, and hematocrit
analyses were also performed on blood samples obtained
from the carotid artery at baseline (0 h) and 3 h and 24 h after
E. coli inoculation using a gas analyzer (Radiometer ABL 555,
Radiometer Medical, Copenhagen, Denmark). Moreover,
white blood cell (WBC) and platelet counts were determined
in blood samples obtained from the cut tip of the tail at
baseline (0 h) and 3 h and 24 h after E. coli inoculation, and
total cell counts were determined using a hemocytometer.
Differential cell counts were carried out on stained films using
oil immersion microscopy; a total of 100 cells were counted
and classified on the basis of normal morphological criteria.
Intravital microscopy of the mesenteric microcirculation and
immunohistochemistry were additionally performed to detect
P-selectin and ICAM-1 24 h after bacterial infusion.
Bacterial inoculum
The inoculum of bacteria was obtained from a culture of
E. coli previously isolated from the lymph nodes of Wistar
rats subjected to small bowel obstruction (23). Culture
samples were plated on agar (TSA Tryptic Soy Agar,
DIFCOs) and incubated for 18 h at 37 ˚C. Two hours before
inoculation, bacterial samples were suspended in saline
(0.9% NaCl) to achieve an optical density of 2.0 at a
wavelength of 625 nm. This bacterial suspension results in
approximately 50% mortality within 7 days.
Intravital microscopy of the mesenteric
microcirculation
Animals were anesthetized with intraperitoneal sodium
pentobarbital (50 mg/kg). After making an abdominal
midline incision, the distal ileum and its accompanying
mesentery were exposed for in vivo microscopic examina-
tion of the microcirculation, as previously described
(24,25). The animals were placed on a specially designed
stage warmed by circulating water maintained at 37 ˚C.
This stage has a transparent platform on which the tissue
to be transilluminated is placed. The mesentery was
continuously perfused throughout the study period with
warmed (37 ˚C) Krebs-Henseleit solution (113 NaCl, 4.7
KCl, 2.5 CaCl2  2 H2O, 25 NaHCO3, 1.1 MgSO4, 1.1 KH2PO4
and 5 mmol/L glucose, pH 7.20-7.40) that was saturated
with a mixture of gases (95% N2 and 5% CO2). This
procedure kept the microcirculatory characteristics
unchanged throughout the intravital microscopic analysis.
The mesenteric microcirculation was assessed after 10 min
of stabilization, and 3-5 postcapillary venules (diameter
20-25 mm) were selected in each animal. A charge-coupled
device color camera (TK-C1380U, JVC Co, Tokyo, Japan) was
incorporated into a trinocular microscope (Axioplan 2, Carl
Zeiss Co, München-Hallbergmoos, Germany) to facilitate
observation of the magnified image (425x) on a microcom-
puter monitor. Analyses of leukocyte-endothelial interactions
were performed online using image-processing computer
software (Axiovision 4.1, Carl Zeiss Co) with an incorporated
modulus of interactive measurements and time lapse. The
images were stored, enabling offline playback analysis.
Rolling leukocytes were defined as WBCs that moved at
a velocity that was significantly slower than that of
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erythrocytes in a given microvessel, and the number of
rolling leukocytes is presented as the mean number of cells
passing a designated line perpendicular to the venular axis
per 3 min. In contrast, a leukocyte was considered to be
adherent to the venular endothelium if it remained stationary
for more than 30 s, and adherent cells were counted in a
100 mm segment of the vessel. The number of leukocytes
accumulating in the connective tissue, adjacent to the studied
postcapillary venule, was determined in a standard area of
5,000 mm2.
Immunohistochemistry for P-selectin and ICAM-1
Animals were anesthetized, as described above, and
exsanguinated via abdominal aorta puncture. The mesentery
was then removed and immediately frozen in a liquid
nitrogen-hexane solution. Serial 8-mm-thick cryosections
were placed on organosilane-coated slides (Dako, Glostrup,
Denmark) and fixed in cold acetone for 10 min prior to direct
immunohistochemical assays. Non-specific sites were blocked
by incubation of the sections with Tris-buffered saline-
Tween20 (TBST) containing 3% bovine serum albumin for 1
h at room temperature. The sections were then incubated
overnight in a humidified chamber (4 ˚C) with either a
monoclonal anti-human P-selectin antibody (CD62P; R&D
Systems Inc, Minneapolis, MN, USA) or a monoclonal anti-
rat ICAM-1 antibody (CD54; Cedarlane Laboratories,
Ontario, Canada). Both antibodies were diluted 1:50 in TBST
containing 1% bovine serum albumin. Endogenous perox-
idase was also blocked (Dual Enzyme Block, Dako) by
incubation of the sections for 15 min at room temperature.
After washing the slides with TBST, the sections were
incubated with secondary antibodies (ADVANCEt HRP
Link, Dako) for 30 min at room temperature, rinsed in TBST,
and then incubated with HRP-conjugated antibodies
(ADVANCEt HRP Enzyme, Dako) for 30 min at room
temperature. After further washes, the samples were devel-
oped with the HRP substrate 3-amino-9-ethylcarbazole
(AEC; Vector Laboratories, Burlingame, CA, USA) for 10
min and counterstained with Mayer’s hematoxylin. The
background reaction was determined in sections incubated
in the absence of primary antibody (negative control). The
slides were mounted, and images were acquired with a DS-
Ri1 digital camera (Nikon, Tokyo, Japan) connected to a
microscope (Nikon) using NIS-Elements BR software
(Nikon). The results are presented as objects 103/mm2.
Statistical analysis
The data are presented as the mean ± SEM. Statistical
comparisons between groups were performed using
ANOVA for repeated measures and one-way ANOVA, and
differences between groups were tested with the Tukey-
Kramer multiple-comparisons test. A value of po0.05 was
considered statistically significant.
’ RESULTS
Effects of the treatments on systemic variables
As illustrated in Figure 1, the effects of the LR and REP
treatments on the MAP and body temperature were assessed
for 30 min following the initiation of E. coli infusion (180 min)
and at 24 h thereafter. Bacteremia caused a slight reduction in
the MAP, which returned to baseline only in the REP group.
Meanwhile, a progressive increase in body temperature was
observed in all groups after bacterial infusion, although
neither the LR nor the REP treatment modified body
temperature during the 30 min following E. coli infusion.
A reduction in the levels of bicarbonate and base excess was
also observed in the first 3 h after bacterial infusion and was
maintained at 24 h. However, there were no differences
between groups (data not shown). Compared with the sham
group, which presented 100% survival, the NT group
exhibited 40% mortality (9/23), and in the LR and the REP
treatment groups, the mortality rates were reduced to 26%
(5/19) and 25% (4/16), respectively.
Effects of the treatments on leukocyte-endothelial
interactions
For observation of the mesenteric microcirculation,
single and unbranched postcapillary venules were
selected; their diameters ranged from 20-25 mm in all
groups. The observed leukocyte-endothelial interactions,
assessed after 24 h of bacteremia, showed that treatment of
the animals with REP solution significantly reduced the
number of rolling leukocytes to the level observed in the
sham group, whereas there was an increased number
(B2.5-fold increase) of rolling cells in the NT and LR
groups. Similarly, REP solution reduced the numbers of
adherent and migrated leukocytes to the levels attained in
Figure 1 - Effects of lactated Ringer’s (LR, 4 mL/kg, n=7) and
Ringer’s ethyl pyruvate (REP, 4 mL/kg LR + 50 mg/kg ethyl
pyruvate, n=6) solutions compared with no treatment (NT, n=7)
and sham operation (SHAM, n=5) on the mean arterial pressure
(mmHg) and body temperature ( ˚C) during live E. coli-induced
bacteremia. The treatments were initiated at 180 min. The data
are presented as the mean± SEM. *po0.05 for LR and NT versus
SHAM.
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the sham group, whereas in both the NT and the LR
groups, there were increased numbers of adherent leuko-
cytes (B3-fold increase) and migrated cells (B3.5-fold)
compared with numbers in the sham group (Figure 2).
Representative photomicrographs are shown in Figure 3.
Analyses of WBC counts showed that the infusion of
bacteria caused leukopenia at 3 h due to a reduction in the
number of lymphocytes and monocytes, followed by
significant leukocytosis with granulocytosis at 24 h.
Furthermore, there was an intense and progressive reduc-
tion in the number of platelets. However, no differences
were observed after treatment of the animals with either
the LR or the REP solution. Meanwhile, sham-operated
rats exhibited transient leukocytosis with granulocytosis
associated with the surgical procedure. The results are
summarized in Table 1.
Effects of the treatments on the expression
of P-selectin and ICAM-1
As illustrated in Figure 4, the expression of P-selectin and
ICAM-1 on mesenteric microvessels was significantly
increased in the NT group compared with the sham group.
Treatment of the animals with REP solution reduced the
expression of both adhesion molecules (P-selectin and
ICAM-1) to the levels attained in the sham group. In
contrast, treatment with LR partially reduced P-selectin
expression but did not modify ICAM-1 expression on
mesenteric microvessels.
’ DISCUSSION
The data presented herein demonstrated that early
administration of ethyl pyruvate during bacteremia induced
by live E. coli efficiently reduces the number of rolling,
adherent and migrated leukocytes in the mesenteric micro-
circulation and down-regulates the endothelial expression of
P-selectin and ICAM-1.
In this experimental model, the development of sepsis was
triggered by live E. coli bacteria obtained from the mesenteric
lymph nodes of rats subjected to strangulated small bowel
obstruction (23) in an attempt to mimic the scenario of
bacterial translocation that might occur in clinical settings. In
small animals, low doses of E. coli have been associated with
minimal early physiological changes, whereas higher
doses result in immediate cardiovascular collapse and early
death (26). In the present study, a bacterial inoculum that
results in approximately 50% mortality within 7 days was
established. As demonstrated herein, the mortality rate was
40% in the NT group. At the onset, the clinical manifestations
were characterized by piloerection and decreased activity,
followed by a slight reduction in the MAP and an increased
Figure 2 - The number of rolling (3 min), adherent (100 mm
venule length) and migrated (5,000 mm2) leukocytes in the rat
mesenteric microcirculation 24 h after intravenous injection of
E. coli. SHAM, sham-operated rats (n=5); NT, non-treated rats
(n=7); LR, lactated Ringer’s solution (4 mL/kg)-treated rats (n=7);
REP (4 mL/kg LR + 50 mg/kg ethyl pyruvate)-treated rats (n=6).
The data are presented as the mean ± SEM. *po0.001 versus
SHAM, wpo0.001 and ?po0.01 versus NT and LR.
Table 1 - White blood cell and platelet counts
Group Baseline 3 h 24 h
SHAM
WBCs/mm3 9,720±1,028 21,460±2,280* 18,575±605*
Granulocytes/mm3 2,800±195 16,340±1,815w 8,700±755y
Lymphocytes/mm3 6,660±824 4,640±490 9,075±517
Monocytes/mm3 260±21 480±73 800±82w
Platelets x103/mm3 858±26 628±32* 817±53
NT
WBCs/mm3 13,430±366 7,280±405 5,864±2,434w
Granulocytes/mm3 6,250±256 4,808±235 9,758±2,291w
Lymphocytes/mm3 6,658±307 2,306±234w 5,762±827
Monocytes/mm3 522±29 166±17w 360±44y
Platelets x103/mm3 884±57 336±27w 74±11w
LR
WBCs/mm3 11,647±928 6,940±336y 22,860±1,319w
Granulocytes/mm3 4,834±293 4,840±522 17,507±1,016w
Lymphocytes/mm3 6,300±732 1,947±248w 4,766±488
Monocytes/mm3 513±73 153±6y 586±101
Platelets x103/mm3 800±53 271±33w 118±15w
REP
WBCs/mm3 12,405±665 6,501±695 6,906±4,790y
Granulocytes/mm3 5,203±283 4,381±561 0,986±4,328*
Lymphocytes/mm3 6,733±380 1,893±297w 5,413±680
Monocytes/mm3 468±68 226±79 506±75
Platelets x103/mm3 806±50 410±58w 78±19w
SHAM, sham-operated, n=5; NT, non-treated, n=7; LR, lactated Ringer’s
solution, n=7; REP, Ringer ’s ethyl pyruvate solution, n=6. The data are
presented as the mean ± SEM. wpo0.001; *po0.01; ypo0.05 versus
baseline values.
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Figure 3 - Representative photomicrographs of the mesenteric microcirculation of a sham-operated rat (A); a control, non-treated rat
(B); a lactated Ringer’s solution-treated rat (C); and a Ringer’s ethyl pyruvate solution-treated rat (D). Increased leukocyte-endothelial
interactions were observed in the non-treated (B) and lactated Ringer’s solution-treated (C) rats compared with the Ringer’s ethyl
pyruvate solution-treated (D) and sham (A) rats. Final magnification, 425X.
Figure 4 - Quantitative evaluation of P-selectin and ICAM-1 expression on rat mesenteric microvessels 24 h after intravenous injection
of E. coli. SHAM, sham-operated rats; NT, non-treated rats; LR, lactated Ringer’s solution (4 mL/kg)-treated rats; REP (4 mL/Kg LR +
50 mg/kg ethyl pyruvate)-treated rats. The presented values are the mean ± SEM for 3 samples/rat, with 3 rats/group. The analyses
were performed using NIS-Elements BR software (Nikon). The results are presented as objectsx103/mm2. *po0.001 versus SHAM,
ypo0.01 versus SHAM and NT, wpo0.001 versus NT, ?po0.01 versus LR.
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heart rate. During the course of bacteremia, our findings
comprised positive criteria for the diagnosis of sepsis and
SIRS, such as elevated temperatures, reduced PCO2 due to
hyperventilation, leukopenia followed by leukocytosis, and
significant thrombocytopenia at the end of the experiments.
Substantial changes in leukocyte-endothelial interactions
were also observed via intra-vital microscopy at the same
time.
In cases of sepsis, leukocyte and endothelial cell activation is a
well-known primary host immune reaction against bacterial
invasion (27). In particular, leukocytes must be activated before
they can attach to the microvessel wall and migrate into the
surrounding tissue. This process is mediated by a variety of
glycoproteins expressed on the surface of leukocytes and
endothelial cells, resulting in increased rolling and sticking of
leukocytes to postcapillary venules. Leukocyte rolling along the
walls of microvessels is specifically mediated by the selectin
family of adhesion molecules, such as P-selectin (28), after which
the leukocytes become firmly adhered to the vascular wall
through the interaction between ICAM-1 on endothelial cells
and b2 integrins (CD11/CD18) on leukocytes (29).
The data presented herein showed that the administration
of ethyl pyruvate was effective in reducing inflammation, as
demonstrated by decreased leukocyte-endothelial interac-
tions and down-regulated expression of P-selectin and
ICAM-1 on mesenteric microvessels in vivo. Indeed, in vitro
studies in human umbilical vein endothelial cells (HUVECs)
(30) and a human lung epithelial cell line (31) demonstrated
that ethyl pyruvate displays anti-inflammatory activity. It
has also been shown that ethyl pyruvate reduces the
adhesion of neutrophils to activated HUVECS; the genera-
tion of interleukin (IL)-8; and the expression of ICAM-1,
vascular cell adhesion molecule (VCAM)-1, and E-selectin on
the surface of endothelial cells (30). Furthermore, exposure of
lung epithelial (A549) cells to ethyl pyruvate in vitro inhibits
generation of the inflammatory cytokines IL-8 and granulo-
cyte colony-stimulating factor and reduces the expression of
ICAM-1 and VCAM-1 and the adhesiveness of human
neutrophils to lung epithelial cells (31).
The beneficial effects of ethyl pyruvate on leukocyte-
endothelial interactions are not related to differences in the
WBC count during the course of bacteremia, as similar
leukocytosis with granulocytosis was observed in NT as well
as LR-treated rats. Furthermore, rats treated with LR solution
exhibited a partial reduction in P-selectin expression. Never-
theless, ICAM-1 expression and microcirculatory injury did not
change with LR treatment. Additionally, ethyl pyruvate did not
modify the progressive reduction in the number of platelets, in
contrast to reported findings, which showed that lipopolysac-
charide-induced disseminated intravascular coagulation in rats
benefits from treatment with ethyl pyruvate (32).
In conclusion, the data presented herein suggest that early
treatment of sepsis with ethyl pyruvate efficiently reduces
microcirculatory dysfunctions and is associated with down-
regulation of P-selectin and ICAM-1 expression.
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